ABSTRACT
Extracorporeal membrane oxygenation (ECMO) has been widely used as a clinical bridge for cardiopulmonary failure. We recently used combined veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and haemoperfusion to successfully treat a patient with acute aconitine poisoning. The patient was admitted to the Emergency Intensive Care Unit (EICU) in a state of coma and shock. Her received comprehensive treatment, including haemoperfusion and anti-shock therapy. 40 minutes after admission, the patient experienced sudden respiratory and cardiac arrest. After conventional defibrillation and cardiopulmonary resuscitation proved ineffective, veno-arterial ECMO was immediately initiated. One hour after initiation of VA-ECMO, the patient's heart rhythm stabilised to sinus rhythm. After 33 h of supportive care, the patient was awake, haemodynamically stable and the VA-ECMO was successfully removed. The patient made full recovery 7 days after admission.
ABSTRACT
As critical splicing regulators, serine/arginine-rich splicing factors (SRSFs) play pivotal roles in carcinogenesis. As dysregulation of SRSFs may confer potential cancer risks, targeting SRSFs could provide important insights into cancer therapy. However, a global and comprehensive pattern to elaborate the molecular characteristics, mechanisms, and clinical links of SRSFs in a wide variety of human cancer is still lacking. In this study, a systematic analysis was conducted to reveal the molecular characteristics and clinical implications of SRSFs covering more than 10000 tumour samples of 33 human cancer types. We found that SRSFs experienced prevalent genomic alterations and expression perturbations in multiple cancer types. The DNA methylation, m6A modification, and miRNA regulation of SRSFs were all cancer context-dependent. Importantly, we found that SRSFs were strongly associated with cancer immunity, and were capable of predicting response to immunotherapy. And SRSFs had colossal potential for predicting survival in multiple cancer types, including those that have received immunotherapy. Moreover, we also found that SRSFs could indicate the drug sensitivity of targeted therapy and chemotherapy. Our research highlights the significance of SRSFs in cancer occurrence and development, and provides sufficient resources for understanding the biological characteristics of SRSFs, offering a new and unique perspective for developing cancer therapeutic strategies.
Subject(s)
Neoplasms , Humans , Serine-Arginine Splicing Factors/genetics , Serine-Arginine Splicing Factors/metabolism , Neoplasms/drug therapy , Neoplasms/genetics , Arginine , Serine/metabolism , Alternative SplicingABSTRACT
Evidence suggests that there is a close association between myeloperoxidase (MPO) gene rs2333227 G>A polymorphism with Alzheimer's disease (AD) susceptibility. We conducted a meta-analysis to explore the precise association between MPO rs2333227 G>A polymorphism and AD susceptibility. Online databases were searched and the relevant information was collected. Crudeodds ratios with 95% confidence intervals were calculated. Trial sequential analysis (TSA), heterogeneity analyses, accumulative analyses, sensitivity analyses, and publication biasestests were performed. Overall, nine publications (ten independent case-controls) were included in this meta-analysis, involving 3260 participants. Pooled results revealed no significant association between MPO rs2333227 G>A polymorphism and AD susceptibility was observed. TSA showed that the present meta-analysis remained inconclusive due to insufficient evidence. In summary, the current meta-analysis indicated that the MPO rs2333227 G>A polymorphism may not be acausalfactor in the development of AD.
Subject(s)
Alzheimer Disease/genetics , Peroxidase/genetics , Genetic Predisposition to Disease , Humans , RiskABSTRACT
BACKGROUND: Mitochondria have been shown to play vital roles during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) development. Currently, it is unclear whether mitochondrial DNA (mtDNA) variants, which define mtDNA haplogroups and determine oxidative phosphorylation performance and reactive oxygen species production, are associated with COVID-19 risk. METHODS: A population-based case-control study was conducted to compare the distribution of mtDNA variations defining mtDNA haplogroups between healthy controls (n = 615) and COVID-19 patients (n = 536). COVID-19 patients were diagnosed based on molecular diagnostics of the viral genome by qPCR and chest X-ray or computed tomography scanning. The exclusion criteria for the healthy controls were any history of disease in the month preceding the study assessment. MtDNA variants defining mtDNA haplogroups were identified by PCR-RFLPs and HVS-I sequencing and determined based on mtDNA phylogenetic analysis using Mitomap Phylogeny. Student's t-test was used for continuous variables, and Pearson's chi-squared test or Fisher's exact test was used for categorical variables. To assess the independent effect of each mtDNA variant defining mtDNA haplogroups, multivariate logistic regression analyses were performed to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) with adjustments for possible confounding factors of age, sex, smoking and diseases (including cardiopulmonary diseases, diabetes, obesity and hypertension) as determined through clinical and radiographic examinations. RESULTS: Multivariate logistic regression analyses revealed that the most common investigated mtDNA variations (> 10% in the control population) at C5178a (in NADH dehydrogenase subunit 2 gene, ND2) and A249d (in the displacement loop region, D-loop)/T6392C (in cytochrome c oxidase I gene, CO1)/G10310A (in ND3) were associated with a reduced risk of severe COVID-19 (OR = 0.590, 95% CI 0.428-0.814, P = 0.001; and OR = 0.654, 95% CI 0.457-0.936, P = 0.020, respectively), while A4833G (ND2), A4715G (ND2), T3394C (ND1) and G5417A (ND2)/C16257a (D-loop)/C16261T (D-loop) were related to an increased risk of severe COVID-19 (OR = 2.336, 95% CI 1.179-4.608, P = 0.015; OR = 2.033, 95% CI 1.242-3.322, P = 0.005; OR = 3.040, 95% CI 1.522-6.061, P = 0.002; and OR = 2.890, 95% CI 1.199-6.993, P = 0.018, respectively). CONCLUSIONS: This is the first study to explore the association of mtDNA variants with individual's risk of developing severe COVID-19. Based on the case-control study, we concluded that the common mtDNA variants at C5178a and A249d/T6392C/G10310A might contribute to an individual's resistance to developing severe COVID-19, whereas A4833G, A4715G, T3394C and G5417A/C16257a/C16261T might increase an individual's risk of developing severe COVID-19.
Subject(s)
COVID-19 , DNA, Mitochondrial , COVID-19/genetics , Case-Control Studies , China , DNA, Mitochondrial/genetics , Humans , Mitochondria/genetics , Phylogeny , Risk FactorsABSTRACT
BACKGROUND Carbon monoxide poisoning is a common reason for Emergency Department admissions worldwide. The symptoms of carbon monoxide poisoning vary from headache and dizziness to severe neuropsychological and cardiac impairment. However, psoas major and iliopsoas hematomas are a rare complication of carbon monoxide poisoning. CASE REPORT A 46-year-old man with carbon monoxide poisoning, after he had been exposed to burning coal without proper ventilation, presented with right low back pain on day 7 after onset. After 2 days, ecchymosis of the right flank occurred, and his hemoglobin concentration gradually decreased. Psoas major and iliopsoas hematomas were shown on computed tomography (CT). The hematomas were successfully treated with transfusions and physical therapy. Owing to the absence of skeletal muscle compartment syndrome, surgical decompression was unnecessary. The patient did not receive anticoagulant therapy during his hospitalization. CONCLUSIONS The direct toxicity of carbon monoxide on the muscles and body weight-induced muscle compression caused skeletal muscle ischemia and necrosis in our patient. The risk of rhabdomyolysis and coagulation abnormality was elevated. Finally, intramuscular hemorrhages occurred in our patient. When a patient has back pain and decreased hemoglobin levels, clinicians should consider the possibility of psoas major and iliopsoas hematomas, and the administration of anticoagulation should be used with caution after admission.
Subject(s)
Carbon Monoxide Poisoning , Muscular Diseases , Anticoagulants/therapeutic use , Hematoma/chemically induced , Humans , Male , Middle Aged , Psoas Muscles/diagnostic imagingABSTRACT
Pentraxin 3 (PTX3) is synthesized locally and released into the circulation, reflecting local inflammation in the cardiovascular system. Therefore, we conducted a study to explore the effect of PTX3 in spontaneously hypertensive heart failure (SHHF) rats. Sprague Dawley (SD) and SHHF rats were treated with recombinant PTX3 protein, and the blood pressure (BP) and echocardiographic parameters were collected. Radioimmunoassay, enzyme immunoassay and enzyme-linked immunosorbent assay (ELISA) were applied to detect plasma levels of atrial/B-type natriuretic peptide (ANP/BNP) and PTX3. The pathological changes in the myocardial tissues were observed by hematoxylin and eosin (HE) and Masson stainings. The mRNA and protein expressions were detected by quantitative real-time reverse-transcription polymerase chain reaction (qPCR) and western blotting. Cardiomyocyte apoptosis was evaluated by TUNEL staining and DNA fragmentation test. Increased plasma concentrations of PTX3 were found in SHHF rats compared with SD rats, which was further enhanced by recombinant PTX3 protein. After injection with recombinant PTX3 protein, the heart function was improved in SHHF rats with the decreased systolic and diastolic BP, and the reduced plasma levels of ANP and BNP. Moreover, PTX3 improved the myocardial damage and interstitial fibrosis in SHHF rats with reduced cardiomyocyte apoptosis and decreased mRNA expressions of pro-inflammatory factors in myocardial tissues. PTX3 could decrease the BP and plasma levels of ANP and BNP in SHHF rats, as well as improve the inflammation, cardiomyocyte apoptosis, and pathological changes of myocardial tissues, suggesting it may be a useful intervention in the treatment of SHHF.
Subject(s)
Apoptosis/drug effects , Blood Pressure/drug effects , C-Reactive Protein/pharmacology , Heart Failure/drug therapy , Hypertension/drug therapy , Myocytes, Cardiac/drug effects , Serum Amyloid P-Component/pharmacology , Animals , Atrial Natriuretic Factor/blood , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Heart Failure/metabolism , Heart Failure/physiopathology , Hypertension/metabolism , Hypertension/physiopathology , Male , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Natriuretic Peptide, Brain/blood , Rats, Inbred SHR , Rats, Sprague-Dawley , Recombinant Proteins/pharmacology , Ventricular Function, Left/drug effectsABSTRACT
Here, we aimed to investigate the role of long noncoding RNA (lncRNA) THRIL in septic-induced acute lung injury. C57BL/6 mice were injected with Adenoviruses (Ad)-shTHRIL or negative control (NC) before caecal ligation and puncture (CLP) operation. MPVECs were transfected with Ad-shTHRIL or NC, followed by lipopolysaccharide (LPS) treatment. MiR-424 and Rho-associated kinase 2 (ROCK2) were predicted and verified as direct targets of THRIL and miR-424, respectively, by using dual-luciferase reporter assay. ROCK2 overexpression vector and shTHRIL were co-transfected into mouse pulmonary microvascular endothelial cells for 24 h before LPS treatment. Our results showed that THRIL was highly expressed in the lung of sepsis mice. CLP triggered severe lung injury and apoptosis in mice, which was abolished by THRIL knockdown. Moreover, CLP treatment visibly increased protein concentration, the number of total cell of neutrophils, and macrophages in bronchoalveolar lavage fluid (BALF). Besides, elevated protein levels of tumor necrosis factor-α, interleukin-1ß, and interleukin-6 were observed in both lung and BALF. However, inhibition of THRIL reduced the number of inflammatory cells and the production of pro-inflammatory cytokines in sepsis mouse model. The effect of THRIL on inflammatory response and apoptosis in the lung was confirmed in sepsis cell model. Moreover, mechanistic studies have shown that THRIL up-regulated ROCK2 level through sponging miR-424. Furthermore, ROCK2 overexpression reversed the inhibitory effects of THRIL knockdown on LPS-induced inflammatory response and apoptosis. Overall, in vivo and in vitro results suggested that THRIL accelerates sepsis-induced lung injury by sponging miR-424 and further restoring ROCK2.
Subject(s)
Acute Lung Injury/immunology , MicroRNAs/metabolism , RNA, Long Noncoding/metabolism , Sepsis/complications , rho-Associated Kinases/genetics , Acute Lung Injury/diagnosis , Acute Lung Injury/pathology , Animals , Apoptosis/genetics , Apoptosis/immunology , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Cell Line , Disease Models, Animal , Endothelial Cells , Endothelium, Vascular/cytology , Gene Knockdown Techniques , Humans , Lipopolysaccharides/immunology , Lung/blood supply , Lung/immunology , Lung/pathology , Male , Mice , Microvessels/cytology , Sepsis/immunology , Signal Transduction/genetics , Signal Transduction/immunology , Up-Regulation/genetics , Up-Regulation/immunologyABSTRACT
Acute respiratory distress syndrome (ARDS) is a life-threatening illness characterized by a complex pathophysiology, involving not only the respiratory system but also nonpulmonary distal organs. Although advances in the management of ARDS have led to a distinct improvement in ARDS-related mortality, ARDS is still a life-threatening respiratory condition with long-term consequences. A better understanding of the pathophysiology of this condition will allow us to create a personalized treatment strategy for improving clinical outcomes. In this article, we present a general overview p38 mitogen-activated protein kinase (p38MAPK) and recent advances in understanding its functions. We consider the potential of the pharmacological targeting of p38MAPK pathways to treat ARDS.
Subject(s)
Inflammation Mediators/metabolism , Respiratory Distress Syndrome/physiopathology , p38 Mitogen-Activated Protein Kinases/metabolism , Humans , Inflammation/immunology , Inflammation/metabolism , Respiratory Distress Syndrome/drug therapy , Respiratory Distress Syndrome/immunology , p38 Mitogen-Activated Protein Kinases/therapeutic useABSTRACT
Background: Anti-EGFR mAb are recommended treatment for metastatic colorectal cancer (mCRC). Accurate mutation profiling and disease monitoring are challenging. The current study investigates the potential use of transrenal DNA as a biomarker for disease management. Methods: Agreement between archival tissue specimens and transrenal DNA extracted from 200 post-treated mCRC patients was determined. Total DNA concentrations were measured and mutations within the KRAS and EGFR genes were profiled for each specimen. To ascertain therapy resistance; patients were serially monitored monthly. Results: Concordance measurement with matched tissues at baseline was remarkably high (92%) for EGFR and KRAS mutations. Sensitivity and specificity were 98.4% and 89.1% respectively. Newly detectable mutations for a subgroup of patients with initial wildtype characteristics were evident after 4 months of anti-EGFR mAb therapy. Survival analysis using adjusted estimates showed that patients detected by transrenal DNA for key mutations or had higher mutant DNA content had poorer outcome. Conclusion: Transrenal DNA offers new options to follow clinical treatment in mCRC. It demonstrates the ability to capture newly acquired mutations that has strong associative links to therapy resistance. Patients with these mutations fared poorly for survival outcomes and indicated possible prognostic value for transrenal DNA detection.
Subject(s)
Antineoplastic Agents, Immunological/therapeutic use , Biomarkers, Tumor/genetics , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/drug therapy , Proto-Oncogene Proteins p21(ras)/genetics , Biomarkers, Tumor/immunology , Cetuximab/therapeutic use , Colorectal Neoplasms/genetics , Colorectal Neoplasms/mortality , DNA, Neoplasm/genetics , DNA, Neoplasm/metabolism , Drug Resistance, Neoplasm/genetics , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/genetics , ErbB Receptors/immunology , Female , Gene Expression , Humans , Lymphatic Metastasis , Male , Middle Aged , Monitoring, Physiologic , Mutation , Panitumumab/therapeutic use , Prognosis , Proto-Oncogene Proteins p21(ras)/immunology , Retrospective Studies , Sensitivity and Specificity , Survival AnalysisABSTRACT
Sepsis is characterized by life-threatening organ dysfunction caused by a deregulated host response to infection. Autophagy is one of the innate immune defense mechanisms against microbial attack. Previous studies have demonstrated that autophagy is activated initially in sepsis, followed by a subsequent phase of impairment. A number of sepsis-related studies have shown that autophagy plays a protective role in multiple organ injuries partly by clearing pathogens, regulating inflammation and metabolism, inhibiting apoptosis and suppressing immune reactions. In this review, we present a general overview of and recent advances in the role of autophagy in sepsis and consider the therapeutic potential of autophagy activators in treating sepsis.
Subject(s)
Autophagy , Sepsis/therapy , Animals , Apoptosis , Disease Models, Animal , Humans , Immunity, Innate , Immunosuppression TherapyABSTRACT
Acute respiratory distress syndrome (ARDS) is a life-threatening illness characterized by a complex pathophysiology, involving not only the respiratory system but also nonpulmonary distal organs. Although advances in the management of ARDS have led to a distinct improvement in ARDS-related mortality, ARDS is still a life-threatening respiratory condition with long-term consequences. A better understanding of the pathophysiology of this condition will allow us to create a personalized treatment strategy for improving clinical outcomes. In this article, we present a general overview p38 mitogen-activated protein kinase (p38MAPK) and recent advances in understanding its functions. We consider the potential of the pharmacological targeting of p38MAPK pathways to treat ARDS.
Subject(s)
Humans , Respiratory Distress Syndrome, Newborn/physiopathology , Inflammation Mediators/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Respiratory Distress Syndrome, Newborn/immunology , Respiratory Distress Syndrome, Newborn/drug therapy , p38 Mitogen-Activated Protein Kinases/therapeutic use , Inflammation/immunology , Inflammation/metabolismABSTRACT
Objective To investigate the effect of estradiol on myocardial voltage-gated calcium channel α1C subunit (CACNA1C) in septic mice. Methods Estradiol benzoate was injected subcutaneously into male mice followed by sepsis induced by cecal ligation and puncture (CLP). The experimental mice were divided into 4 groups: sepsis group, estradiol-treated sepsis group, sham group, estradiol-treated sham group. 3, 6, 12, 24 hours after CLP, the mRNA level of CACNA1C in left ventricular was detected by real-time fluorescent quantitative PCR, the protein expression level of CACNA1C was detected by Western blot analysis. The expression and distribution of CACNA1C were detected by immunohistochemical staining at 12 hours after CLP. Results The expression of CACNA1C was significantly decreased in sepsis group at 6 hours and remained at this low level at 12, 24 hours. The expression of CACNA1C in estradiol-treated sepsis group did not change at 3, 6 and 12 hours, but was significantly decreased at 24 hours. Conclusion Exogenous estradiol can increase the left ventricular level of CACNA1C in septic mice.
Subject(s)
Calcium Channels, L-Type/metabolism , Estradiol/pharmacology , Myocardium/metabolism , Sepsis/metabolism , Animals , Male , MiceABSTRACT
Oxidative stress reactions play an important role in the pathogenesis of intracranial aneurysm (IA). p22phox is involved in the oxidative stress reaction, and it is a critical subunit of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. The present study investigated the association of genetic variants within the gene encoding p22phox214T/C with IA. The p22phox214T/C gene polymorphisms in 192 cases of IA and 112 controls were analyzed by polymerase chain reactionrestriction fragment length polymorphism (PCRRFLP). The mRNA expression of NADPH oxidase was also analyzed by RTPCR. The results of RTPCR were validated by ELISA. In a rabbit model of elastaseinduced aneurysm, we used edaravone for antioxidative stress treatment to observe the curative effects. In the clinical cases, a significant difference in p22phox214T/C allele frequencies in the IA group was observed compared with the control group (P<0.001). The expression level of NADPH oxidase was differed significantly between the IA group and the control group. In the rabbit model of elastaseinduced aneurysm, the success rate of the aneurysmal model in the edaravone group and the wound ulcer rate were lower than those in the control group. In addition, the diameter of the aneurysm was smaller than in the edaravone group than in the control group (3.26±0.13 mm vs. 3.85±0.07 mm), and the expression of matrix metalloproteinase9 (MMP9) was significantly lower than that in the control group (P<0.0001). Thus, these data suggest the active participation of p22phox214T/C in the formation of IA and the suppressive potential of edaravone against IA formation.
Subject(s)
Edaravone/therapeutic use , Intracranial Aneurysm/drug therapy , Intracranial Aneurysm/genetics , NADPH Oxidases/genetics , Neuroprotective Agents/therapeutic use , Polymorphism, Single Nucleotide , Adolescent , Adult , Aged , Animals , Case-Control Studies , Female , Genetic Predisposition to Disease , Humans , Intracranial Aneurysm/pathology , Male , Middle Aged , Rabbits , Young AdultABSTRACT
OBJECTIVE: To clarify the influence of MicroRNA-27a (miR-27a)-mediated Wnt/ß-catenin pathway on the myocardial fibrosis in rats with chronic heart failure (CHF). METHODS: The CHF rat models were constructed and randomly divided into four groups (Sham, Model, AntagomiR-27a, and NC antagomiR-27a groups). Echocardiography was used to test the cardiac function indexes, HE (haematoxylin-eosin) staining to observe the pathological injury of myocardium, Masson staining to analyze the collagen volume fraction (CVF), and qRT-PCR (quantitative real-time PCR) and Western blotting to detect the expressions of miR-27a and Wnt/ß-catenin pathway-related proteins. Besides, cardiomyocytes were isolated and transfected with miR-27a mimic or miR-27a inhibitor to detect the expressions of Wnt/ß-catenin pathway. RESULTS: The CHF rats were significantly increased in LVESD (left ventricular end systolic diameter) and LVEDD (left ventricular end diastolic diameter), and clearly reduced in FS (fractional shortening) and EF (left ventricular ejection fraction) (all P < 0.05). Moreover, LVWI (left ventricular mass index) and CVF (Collagen Volume Fraction), type I and type III collagen, and the ratio of type I/III collagen, as well as the expression of miR-27a, TGF-ß1 and p-Smad2/3, ß-catenin, p-GSK-3ß and α-SMA were also elevated (all P < 0.05). Additionally, the CHF rats treated with AntagomiR-27a were improved in these indexes, and the expression of miR-27a and Wnt/ß-catenin pathway was significantly inhibited (all P < 0.05). Furthermore, cardiomyocytes transfected with miR-27a inhibitor significantly decreased the levels of miR-27a and Wnt/ß-catenin pathway (all P < 0.05). CONCLUSION: Down-regulation of miR-27a may inhibit the Wnt/ß-catenin pathway to reduce the deposition of myocardial collagen, prevent myocardial fibrosis and improve cardiac function. This article is protected by copyright. All rights reserved.
ABSTRACT
OBJECTIVE: Wasp venom is a potentially important natural drug, but it can cause hypersensitivity reactions. The purpose of the present study was to systematically study the epitopes of wasp venom. METHODS: Using a random 12-peptide phage library, we performed antibody-binding epitope panning on ten serum samples from wasp sting victims at 3 h and 4 days after the sting. The panning epitopes were identified by high-throughput sequencing and matched with wasp venom proteins by BLAST. The panned antibody-binding epitopes were verified by ELISA. RESULTS: A total of 35 specific potential wasp venom epitopes in 4 days were identified. Amongst them, twelve peptide epitopes were matched with nine wasp venom proteins, namely, vitellogenin precursor, hexamerin 70b precursor, venom carboxylesterase-6 precursor, MRJP5, major royal jelly protein 8 precursor, venom acid phosphatase Acph-1 precursor, phospholipase A2, venom serine protease 34 precursor, and major royal jelly protein 9 precursor. The changes in serum IgM antibodies induced by wasp venom were confirmed by ELISA based on the 12 peptide epitopes. CONCLUSION: The nine wasp venom proteins are potential allergens, which should be excluded or modified in the potential biomedical applications of wasp venom.
Subject(s)
Allergens/immunology , Epitopes/immunology , Hypersensitivity/immunology , Wasp Venoms/immunology , Adult , Animals , Antibodies/blood , Antibodies/immunology , Epitopes/classification , Female , Humans , Hypersensitivity/prevention & control , Immunoglobulin M/blood , Immunoglobulin M/immunology , Peptides/immunology , Wasps/immunologyABSTRACT
To analyze the dynamic changes of serum metabolomics in wasp sting victims, we collected serum from 10 healthy volunteers and 10 patients who had been stung 3 hours, 24 hours, and 72 hours before sample collection. We analyzed the metabolomics by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) techniques and then performed enrichment analysis. A total of 838 metabolites were identified. Serum metabolomics analysis using MetaboAnalyst revealed 289 metabolites that were significantly different among patients in the 3-hour group versus healthy controls (P<0.001). Pathway analysis of those metabolites indicated that those metabolic sets were associated with sphingolipid metabolism. Based on the differences among the control, 3-hour, 24-hour, and 72-hour groups, we classified serum metabolites into different categories. The first and second categories included 297 and 280 metabolites that were significantly different in terms of concentration among healthy controls versus the participants whose sera were analyzed 3 hours, 24 hours, and 72 hours after wasp stings. Pathway analysis of those metabolites indicated that those metabolic sets were associated with thiamine metabolism. The third category included 269 significant metabolites. The fourth category included 28 significant metabolites. Pathway analysis of the metabolites in third and fourth categories indicated that those metabolic sets were associated with phenylalanine, tyrosine, and tryptophan biosynthesis. The fifth category included 31 metabolites, which were not significantly different between the control and 3-hour groups but were higher in concentration in the 24-hour and 72-hour groups. Pathway analysis of the fifth category of significant metabolites identified linoleic acid metabolism. In conclusion, multiple metabolic pathways are associated with wasp stings, and these might provide a basis for exploring mechanisms of wasp sting injury and potential targets for therapy.
Subject(s)
Bites and Stings/metabolism , Metabolome/physiology , Serum/metabolism , Adult , Animals , Case-Control Studies , Female , Humans , Male , Metabolic Networks and Pathways/physiology , Metabolomics/methods , Phenylalanine/metabolism , Tryptophan/metabolism , Tyrosine/metabolism , Wasps/pathogenicityABSTRACT
Planar nanocrystals with multiple branches exhibit unique localized surface plasmon resonance properties and great promise in optical applications. Here, we report an aqueous synthesis of Pd@AuCu core-shell planar tetrapods through preferential overgrowth on Pd cubic seeds. The large lattice mismatch between the Pd core and the AuCu shell is the key to induce the formation of branches under sluggish reduction kinetics. Meanwhile, the capping effect of cetyltrimethylammonium chloride on the {100} facets of Pd cubes with an aspect ratio of 1.2 can determine the growth direction of AuCu branches to form a planar structure. Through simply varying the amounts of Pd cubic seeds, the sizes of products can be well-controlled in the range from 33 to 70 nm. With the manipulation of sizes, the peak position of in-plane dipole resonance can be adjusted from visible to near-infrared region. Due to the presence of tips and edges in the branches, planar tetrapods exhibited excellent surface-enhanced Raman scattering performance with an enhancement factor up to 9.0 × 10(3) for 70 nm Pd@AuCu planar tetrapods.
ABSTRACT
Paroxysmal sympathetic hyperactivity (PSH) is a common complication of various acquired brain injuries such as traumatic brain injury, subarachnoid hemorrhage, anoxic brain injury, intracerebral hemorrhage, and others. It is manifested by tachycardia, hypertension, tachypnea, diaphoresis, and dystonic posturing. The development of PSH can prolong hospitalization and lead to secondary brain injury and even death. Despite the awareness of the serious clinical impact, there is no consensus on diagnostic criteria. Thus, misdiagnosis and delayed recognition is very common. Most of the current treatment programs come from case reports and small case series; there are very few large-scale randomized controlled trials. Generally accepted medications are opioids, ß-blockers and gabapentin (usually used in combination). However, the efficacy of these drugs has not been systematically assessed. The purpose of this review is to determine the treatment strategies and drugs commonly used for PSH at the overall level.
Subject(s)
Brain Injuries/complications , Primary Dysautonomias/drug therapy , Humans , Primary Dysautonomias/diagnosis , Primary Dysautonomias/etiologyABSTRACT
Recently, metal nanoframes have received increased attention due to their unique spatial and physicochemical, e.g., catalytic and plasmonic properties. So far, a variety of synthetic procedures have been developed to fabricate metal nanoframes with different shapes, sizes and compositions. Typical synthesis of metal nanoframes involves two stages: 1) formation of solid nanocrystals and 2) hollowing out the interiors and side faces. In this review, solution-phase synthetic strategies are summarized, based on galvanic replacement reactions, oxidative etching, the Kirkendall effect, electrodeposition, and template-assisted growth, as well as one-pot synthesis. Their potential applications in catalysis and optical sensing are overviewed as well.
ABSTRACT
Forming core-shell and alloy structures offers generally two ways to design efficient Pt-based catalysts for oxygen reduction reaction (ORR). Here, we combined these two strategies and invented a versatile aqueous route to synthesize octahedral Pd@Pt1.8Ni core-shell nanocrystals. The Pt/Ni atomic ratios in the resultant shells can be varied from 0.6 to 1.8, simply by changing the amounts of Pt and Ni precursors, with the other conditions unchanged. Experimental studies showed that the mass activities of as-prepared catalysts were 5 times higher than that of the commercial Pt/C. We believe that the ultrathin PtNi shells enclosed by {111} facets made it possible to reduce the Pt content while retaining the catalytic activity toward ORR. This strategy may be extended to the preparation of other multimetallic nanocrystals with shaped and ultrathin alloy shells, which is conducive to design highly active catalysts.